Latest Generic Drug Approvals
First Time Generics are those drug products that have never been approved before as generic drug products and are new generic products to the marketplace.
First-Time Generic Approvals April 2014
- Solifenacin Succinate Tablets 5 mg and 10 mg
Approved: April 2, 2014 - Teva Pharmaceuticals, Inc.
Generic for: Vesicare
- Nevirapine Extended Release Tablets 400 mg
Approved: April 3, 2014 - Apotex Inc.; Sandoz Inc. Generic for: Viramune XR
- Omega-3-Acid Ethyl Esters Capsules 1 gram
Approved: April 7, 2014 - Teva Pharmaceuticals, Inc.
Generic for: Lovaza
- Eszopiclone Tablets 1 mg, 2 mg and 3 mg
Approved: April 15, 2014 - Teva Pharmaceuticals, Inc.; Sun Pharma Global FZE; Lupin Pharmaceuticals, Inc.; Glenmark Generics Inc., USA; Roxane Laboratories, Inc.
Generic for: Lunesta
Approved: April 16, 2014 - Mylan Pharmaceuticals Inc.
Generic for: Ortho Evra